NCT04473300

Brief Summary

Novel coronavirus (SARS-CoV-2: severe acute respiratory coronavirus 2) pneumonia often develop the acute respiratory distress syndrome (ARDS). Lung protective ventilation strategy consisting of low tidal volume and high positive end-expiratory pressure (PEEP) is recommended. However, it is not clear whether injured lungs from SARS-CoV-2 pneumonia have the same mechanical properties, especially response to PEEP as common ARDS. Therefore, the investigators propose an observational study to analyze respiratory mechanics and lung recruitablity using EIT (electrical impedance tomography) in patients with ARDS due to SARS-CoV-2 pneumonia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 16, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

July 1, 2021

Status Verified

July 1, 2020

Enrollment Period

10 months

First QC Date

July 14, 2020

Last Update Submit

June 30, 2021

Conditions

Keywords

SARS-CoV-2electrical impedance tomographypositive end expiratory pressure

Outcome Measures

Primary Outcomes (1)

  • The distribution of ventilation

    The distribution of ventilation measured by EIT at PEEP 5 and 15.

    Through study completion (up to 24 hours)

Secondary Outcomes (4)

  • Silent spaces

    Through study completion (up to 24 hours)

  • Respiratory system compliance

    Through study completion (up to 24 hours)

  • Oxygenation

    Through study completion (up to 24 hours)

  • Dead space ventilation ratio

    Through study completion (up to 24 hours)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients with ARDS due to SARS-CoV-2 pneumonia under mechanical ventilation in intensive care unit.

You may qualify if:

  • Patients with positive SARS-CoV-2 infection*
  • Patients with ARDS under mechanical ventilation**
  • Patients ≧ 18 years old
  • Definition of SARS-CoV-2 infection positive: SARS-CoV-2 infection is defined as being positive in RT-PCR (real time reverse transcriptase-polymerase chain reaction) assay using nasal or pharyngeal swab samples.
  • Definition of ARDS is as per the Berlin definition (PaO2/FiO2 ≦ 300 mmHg with PEEP ≧ 5 cmH2O)

You may not qualify if:

  • Contraindication for EIT monitoring
  • Unstable spine or pelvic fractures
  • Pacemaker, automatic implantable cardioverter defibrillator
  • Skin lesions between the 4th and 5th ribs where the EIT belt is worn
  • Pregnancy
  • DNR (do-not-resuscitate)
  • Increased intracranial pressure (\> 18 mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Osaka University Hospital

Suita, Osaka, 565-0871, Japan

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Takeshi Yoshida, M.D., Ph.D.

    Osaka University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2020

First Posted

July 16, 2020

Study Start

May 11, 2020

Primary Completion

February 28, 2021

Study Completion

February 28, 2021

Last Updated

July 1, 2021

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations